24
Oct
2023

Biofarma Group

Exhibitor at CPHI Barcelona 2023 stand 3P30, Contract Manufacturing and Services
About Us

Biofarma Group is the new Italian and European market leader in the development, manufacture and packaging of supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties.
At our 4 manufacturing sites located in the Friuli Venezia Giulia, Veneto and Lombardy regions of Italy, we create customised solutions and provide our clients with a fully-comprehensive and integrated turnkey service. 
Our flair for innovation allows us to grasp market opportunities and offer our clients ready-to-sell solutions that will set them aside from...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 3P30, Contract Manufacturing and Services

Products Featured at CPHI Barcelona 2023

  • Lenoid

    Product Lenoid

    Hemorrhoidal disease (HD) is one of the most common anorectal benign disorder affecting millions of people around the world. Almost 75% of all adults develop piles at some point in their life. Lenoid™ cream is a medical device indicated for the treatment of hemorrhoidal disease (internal and external hemor...
  • Respecta Balance Gel

    Product Respecta Balance Gel

    Respecta® Balance Gel is a medical device specifically studied for rebalancing the physiological pH and vaginal microbiota that represents an effective adjuvant for the treatment of vaginitis and vaginosis.

    Thanks to the synergistic action of its components:
    • Restores physiological vagina...
  • Gastro Stop

    Product Gastro Stop

    GASTRO STOP is a class IIa medical device, having an anti-reflux action and containing sodium alginate, sodium bicarbonate, sodium carbonateand calcium carbonate.

    PRODUCT

    The product is indicated to reduce gastro-oesophageal reflux diseasesymptoms, including heartburn, gastric pyrosis during ...
  • VIJOINT HCC

    Product VIJOINT HCC

    Vijoint HCC is a patented fixed combination of Hyaluronic Acid (HA) sodium salt 2%, chondroitin-Sulfate 2% (CS) and Hydroxypropyl beta-Cyclodextrin 1%.
    HA AND CS ACT IN SYNERGY TO CONTRAST DISEASE SYMPTOMS AND SLOW DOWN ITS PROGRESSION.

    YOUNG TARGETHYALURONIC A...
  • VIJOINT - VISCOSUPPLEMENTATION

    Product VIJOINT - VISCOSUPPLEMENTATION

    Vijoint, provides a linear intermediate (~1,000-1,500 KDa) Molecular Weight Hyaluronic Acid (HA) for intra-articular viscosupplementation. A recent review highlights that: • HA preparations with Molecular weight (MW) between 500 and 1,500 KDa can achieve maximum concentration in the joint • th...